J&J HALTS SUPPLY OF PERSONAL-CARE PRODUCTS IN RUSSIA

Tue 29 March 2022:

On Tuesday, Johnson & Johnson said that it would stop selling personal care goods in Russia, joining a growing list of corporations that have scaled back their operations in the country in response to Russia’s invasion of Ukraine.

Because pharmaceuticals and medical devices are exempt from Western sanctions, J&J said it would continue to supply them in the region. It will not, however, enroll any further patients in the clinical medication trials it is conducting in Russia, as it previously stated.

The company, which gets approximately 1% of its revenues from Russia, has previously stated that pharmaceuticals account for half of its business in the country, and that the majority of its consumer health product portfolio is in the essential health area of over-the-counter drugs.

President Volodymyr Zelenskiy of Ukraine urged pharmaceutical companies, including J&J, to join conglomerates withdrawing altogether from Russia earlier this month.

PepsiCo Inc, Procter & Gamble Co, and Nestle SA have all stated that they will maintain a presence in Russia to supply essential nourishment and hygiene supplies.

J&J previously stated that it would halt enrolment in clinical studies in Russia, Ukraine, and Belarus, but that it would continue to provide necessary health items.

Large American pharmaceutical companies Eli Lilly and Company and Pfizer have announced plans to withdraw their investments and marketing from Russia, but have committed to continue supplying medicine and medical equipment.

SOURCE: INDEPENDENT PRESS AND NEWS AGENCIES

___________________________________________________________________________________________________________________________________________

FOLLOW INDEPENDENT PRESS:

TWITTER (CLICK HERE)
https://twitter.com/IpIndependent